The integration of pharmacological advancements in respiratory care has been noteworthy. Specifically, the combination of tiotropium bromide and olodaterol has garnered attention. This drug duo holds potential for chronic obstructive pulmonary disease (COPD) management. In contrast, epilepsy, a neurological condition, reveals its own complexities. Both areas, though distinct, exhibit overlapping research interests, particularly in vascular […]